학술논문

Entospletinib, a potent SYK inhibitor, blocks constitutive and FCgRI activated signaling in FLT3-ITD cell lines
Document Type
Journal
Source
CANCER RESEARCH; JUL 2018, 78 13, 2p. Supplement: S
Subject
Language
English
ISSN
15387445